|
|
Gene Symbol |
CCL2 |
|
Aliases |
GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF |
|
Entrez Gene ID |
|
|
Gene Name |
C-C motif chemokine ligand 2 |
|
Chromosomal Location |
17q12 |
|
HGNC ID |
|
|
Summary |
This gene is one of several cytokine genes clustered on the q-arm of chromosome 17. Chemokines are a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of N-terminal cysteine residues of the mature peptide. This chemokine is a member of the CC subfamily which is characterized by two adjacent cysteine residues. This cytokine displays chemotactic activity for monocytes and basophils but not for neutrophils or eosinophils. It has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis and atherosclerosis. It binds to chemokine receptors CCR2 and CCR4. [provided by RefSeq, Jul 2013]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
C-C motif chemokine 2, chemokine (C-C motif) ligand 2, monocyte chemoattractant protein-1, monocyte chemotactic and activating factor, monocyte chemotactic protein 1, monocyte secretory protein JE, small inducible cytokine A2 (monocyte chemotactic protein 1, homologous to mouse Sig-je), small inducible cytokine subfamily A (Cys-Cys), member 2, small-inducible cytokine A2 |
|
Function |
Acts as a ligand for C-C chemokine receptor CCR2 (PubMed:9837883, PubMed:10587439, PubMed:10529171). Signals through binding and activation of CCR2 and induces a strong chemotactic response and mobilization of intracellular calcium ions (PubMed:9837883, PubMed:10587439). Exhibits a chemotactic activity for monocytes and basophils but not neutrophils or eosinophils (PubMed:8627182, PubMed:9792674, PubMed:8195247). May be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis (PubMed:8107690). |
|
|
|
|
|
UniProt |
|
|
PDB |
1DOK, 1DOL, 1DOM, 1DON, 1MCA, 1ML0, 2BDN, 2NZ1, 3IFD, 4DN4, 4R8I, 4ZK9 |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000485659 |
|
P98088 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Arteriosclerosis |
|
Heart Diseases |
|
Atherosclerosis |
|
Myocardial Ischemia |
|
Hypertensive disease |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Status Dysraphicus |
|
Hyperoxaluria |
|
Digestive System Diseases |
Liver Fibrosis |
|
Crohn Disease |
|
Colitis |
|
Hepatitis |
|
Enteritis |
|
Liver Diseases |
|
Liver Cirrhosis |
|
Ear Or Mastoid Diseases |
Meniere Disease |
|
Endocrine System Diseases |
Thyroid Diseases |
|
Glomerulosclerosis |
|
PCOS |
|
Immune System Diseases |
Autoimmune Hepatitis |
|
Neoplasms |
Endometrial Cancer |
|
Thyroid Cancer |
|
Mouth Neoplasms |
|
Carotid Atherosclerosis |
|
Carcinoma |
|
Multiple Myeloma |
|
Nervous System Diseases |
Cerebral Thrombosis |
|
Status Epilepticus |
|
Middle Cerebral Artery Syndrome |
|
Cerebral Ischemia |
|
Cerebral Artery Infarction |
|
Muscular Dystrophy |
|
Moyamoya disease |
|
Brain Infarction |
|
Compression of spinal cord |
|
Carotid Artery Diseases |
|
Spina Bifida |
|
Petit mal status |
|
Nutritional and Metabolic Diseases |
Tumoral calcinosis |
|
Metabolic Syndrome X |
|
Psychiatric/Brain disorders |
Manic Disorder |
|
Bipolar Disorder |
|
Schizophrenia |
|
Mental Depression |
|
Obstructive Sleep Apnea |
|
Renal Disorder |
Nephritis, Interstitial |
|
Diabetic Nephropathy |
|
Kidney Failure |
|
Nephritis |
|
Glomerulonephritis |
|
Oxalosis |
|
Reproductive disorders |
Preeclampsia |
|
Respiratory Tract Diseases |
Pulmonary Fibrosis |
|
Silicosis |
|
Asthma |
|
Pneumonia |
|
Pulmonary Tuberculosis |
|
Respiratory Distress Syndrome |
|
Chronic Lung Injury |
|
Pleural Diseases |
|
Bronchial hyperreactivity |
|
Influenza |
|
Skin and Connective Tissue Diseases |
Leishmaniasis |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
C-reactive protein |
Vascular damage and cardiovascular disease |
|
Rotterdam criteria |
Related
|
|
Serum monocyte chemoattractant protein-1 levels were positively correlated with serum LH, T, and C-reactive protein levels. |
|
IL-6,MMP2,sICAM-1,CRP,PAI-1 |
Chronic low-level inflammation,atherogenesis,hyperandrogenism,hyperglycemia, |
|
Rotterdam criteria |
Related
|
|
The study concludes that both PCOS and obesity contribute to a proatherogenic state; but in women with PCOS, abdominal adiposity and hyperandrogenism may exacerbate the risk of atherosclerosis. |
|
Prolactin |
Obesity, hyperinsulinemia, and insulin resistance |
|
|
Related
|
|
The serum level of MCP-1 is associated with the LH level in POCS patients. |
|
Apo A,ApoB, LP(a),PRL,E2 |
|
|
|
Related
|
|
PCOS obese and non-obese patients had higher serum MCP-1 levels than controls. |
|
MIP-1alpha and MIF |
|
|
|
Related
|
|
Hirsute patients had significantly increased MCP-1 |
|
Serum CRP |
Low-grade chronic inflammation,atherogenesis |
|
|
Related
|
|
Patients with PCOS suffer low-grade chronic inflammation indicated by higher levels of CRP and MCP-1, which could lead to increased risk of atherogenesis. |
|
|
|
|